Study shows aspirin before a diagnosis may lower colorectal cancer mortality
ATLANTA – FEBRUARY 2, 2021 – A new study finds that long-term aspirin use before a diagnosis of colorectal cancer (CRC) may be associated with lower CRC-specific mortality. The report that appears in JNCI: The Journal of the National Cancer Institute, suggests that the findings for pre-diagnosis aspirin use might help reduce CRC mortality in…